Neogen Corporation Total Assets
Neogen Corporation (NEOG) had Total Assets of $3.35 billion as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-07-30
- 2026-05-31: Assets $3.35B.
- 2026-02-28: Assets $3.36B.
- 2025-11-30: Assets $3.36B.
- 2025-08-31: Assets $3.38B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-05-31 | $3.35B 10-K · filed 2026-07-30 | |
| 2026-02-28 | $3.36B 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $3.36B 10-Q · filed 2026-01-08 | |
| 2025-08-31 | $3.38B 10-Q · filed 2025-10-09 | |
| 2025-05-31 | $3.44B 10-K · filed 2026-07-30 | $3.44B 10-K · filed 2025-07-30 |
| 2025-02-28 | $4.04B 10-Q · filed 2025-04-09 | |
| 2024-11-30 | $4.05B 10-Q · filed 2025-01-15 | |
| 2024-08-31 | $4.50B 10-Q · filed 2024-10-10 | |
| 2024-05-31 | $4.55B 10-K · filed 2025-07-30 | |
| 2024-02-29 | $4.58B 10-Q · filed 2025-04-09 | |
| 2023-11-30 | $4.60B 10-Q · filed 2025-01-15 | |
| 2023-08-31 | $4.56B 10-Q · filed 2024-10-10 | |
| 2023-05-31 | $4.55B 10-K · filed 2025-07-30 | |
| 2023-02-28 | $4.51B 10-Q · filed 2024-04-09 | |
| 2022-11-30 | $4.56B 10-Q · filed 2024-01-09 | |
| 2022-08-31 | $977.40M 10-Q · filed 2023-10-10 | |
| 2022-05-31 | $992.93M 10-K · filed 2024-07-30 | |
| 2022-02-28 | $981.21M 10-Q · filed 2023-04-04 | |
| 2021-11-30 | $967.93M 10-Q · filed 2023-01-09 | |
| 2021-08-31 | $932.11M 10-Q · filed 2022-09-30 | |
| 2021-05-31 | $920.19M 10-K · filed 2023-08-15 | |
| 2021-02-28 | $880.22M 10-Q · filed 2022-04-01 | |
| 2020-11-30 | $845.63M 10-Q · filed 2021-12-30 | |
| 2020-08-31 | $821.59M 10-Q · filed 2021-09-30 | |
| 2020-05-31 | $797.18M 10-K · filed 2022-07-27 | |
| 2020-02-29 | $773.50M 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $750.59M 10-Q · filed 2020-12-29 | |
| 2019-08-31 | $721.14M 10-Q · filed 2020-09-30 | |
| 2019-05-31 | $695.74M 10-K · filed 2021-07-30 | |
| 2019-02-28 | $672.59M 10-Q · filed 2020-04-03 | |
| 2018-11-30 | $660.49M 10-Q · filed 2019-12-27 | |
| 2018-08-31 | $640.93M 10-Q · filed 2019-09-26 | |
| 2018-05-31 | $618.01M 10-K · filed 2020-07-30 | |
| 2018-02-28 | $595.60M 10-Q · filed 2019-03-29 | |
| 2017-11-30 | $581.03M 10-Q · filed 2018-12-28 | |
| 2017-08-31 | $547.33M 10-Q · filed 2018-10-05 | |
| 2017-05-31 | $528.41M 10-K · filed 2019-07-30 | |
| 2017-02-28 | $507.30M 10-Q · filed 2018-03-29 | |
| 2016-11-30 | $487.31M 10-Q · filed 2018-01-05 | |
| 2016-08-31 | $468.62M 10-Q · filed 2017-09-29 | |
| 2016-05-31 | $449.94M 10-K · filed 2018-07-27 | $451.71M 10-K · filed 2016-07-29 |
| 2016-02-29 | $432.24M 10-Q · filed 2017-03-31 | |
| 2015-11-30 | $425.78M 10-Q · filed 2016-12-29 | |
| 2015-08-31 | $409.39M 10-Q · filed 2016-09-30 | |
| 2015-05-31 | $392.18M 10-K · filed 2017-07-28 | |
| 2015-02-28 | $378.44M 10-Q · filed 2016-03-31 | |
| 2014-11-30 | $365.92M 10-Q · filed 2016-01-08 | |
| 2014-08-31 | $357.66M 10-Q · filed 2015-09-30 | |
| 2014-05-31 | $345.30M 10-K · filed 2016-07-29 | |
| 2014-02-28 | $330.35M 10-Q · filed 2015-04-01 | |
| 2013-11-30 | $319.71M 10-Q · filed 2014-12-30 | |
| 2013-08-31 | $308.14M 10-Q · filed 2014-09-30 | |
| 2013-05-31 | $290.56M 10-K · filed 2015-07-30 | |
| 2013-02-28 | $281.02M 10-Q · filed 2014-04-04 | |
| 2012-11-30 | $269.67M 10-Q · filed 2014-01-09 | |
| 2012-08-31 | $260.80M 10-Q · filed 2013-09-30 | |
| 2012-05-31 | $251.60M 10-K · filed 2014-07-30 | |
| 2012-02-29 | $240.35M 10-Q · filed 2013-03-28 | |
| 2011-11-30 | $234.32M 10-Q · filed 2012-12-28 | |
| 2011-08-31 | $227.62M 10-Q · filed 2012-09-28 | |
| 2011-05-31 | $219.66M 10-K · filed 2013-07-30 | |
| 2011-02-28 | $209.16M 10-Q · filed 2012-03-30 | |
| 2010-11-30 | $203.68M 10-Q · filed 2011-12-30 | |
| 2010-08-31 | $190.71M 10-Q · filed 2011-09-30 | |
| 2010-05-31 | $180.23M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |